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Elucidating the molecular mechanisms underlying quantitative neurocognitive phenotypes will further our
understanding of the brain’s structural and functional architecture and advance the diagnosis and treatment
of the psychiatric disorders that these traits underlie. Although many neurocognitive traits are highly heri-
table, little progress has been made in identifying genetic variants unequivocally associated with these
phenotypes. A major obstacle to such progress is the difficulty in identifying heritable neurocognitive
measures that are precisely defined and systematically assessed and represent unambiguous mental
constructs, yet are also amenable to the high-throughput phenotyping necessary to obtain adequate power
for genetic association studies. In this perspective we compare the current status of genetic investigations of
neurocognitive phenotypes to that of other categories of biomedically relevant traits and suggest strategies
for genetically dissecting traits that may underlie disorders of brain and behavior.Genetic investigations of neurocognitive phenotypes aim to
elucidate mechanisms underlying cognitive function and
behavior, and to further our understanding of the pathogenesis
of neuropsychiatric disorders. A series of advances in genomics
and bioinformatics have transformed human genetics over the
past decade. For example, when genome-wide association
studies (GWAS) began, in about 2005, only a few genes associ-
ated with complex human traits had yet been identified. By 2010,
GWAS had detected almost 1000 distinct genetic loci unequivo-
cally associated with one or more such traits, i.e., those having
achieved a commonly accepted statistical threshold for
genome-wide significance (p < 53108) and having been repli-
cated in at least one independent sample (http://www.genome.
gov/gwastudies/). During this period cognitive neuroscience
has also experienced a technology-driven transformation; for
example, the proliferation of various neuroimaging modalities
has led to the delineation of awide and still growing array of novel
phenotypes. The apparent high heritability of many of these
measures has in turn led to intense efforts to identify the respon-
sible genetic loci. While several putative neurocognitive trait
associations have been the focus of considerable attention,
human geneticists have accepted almost none of them as having
achieved validation, given the widely agreed upon statistical
threshold noted above. At the same time, the genome-wide
approaches, which have been so clearly validated for a wide
variety of complex traits, have not yet yielded clear associations
for neurocognitive phenotypes. There is thus currently a discon-
nect between the fields of human genetics and cognitive neuro-
science. In this perspective we discuss the basis for this gap and
suggest strategies for bridging it. We illustrate key points by218 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.comparing and contrasting investigations of several prominent
neurocognitive phenotypes with genetic studies of various
‘‘medical’’ traits. A comprehensive review of neurocognitive
measures is, however, beyond our purview.
Genetic Architecture and Genetic Dissection
of Complex Phenotypes
Understanding the challenges involved in genetic elucidation of
neurocognitive phenotypes requires an appreciation of the
current state of knowledge regarding the genetic architecture
of human phenotypes generally. Among the greatest scientific
advances of the past few decades has been the mapping of
human genomes at increasingly high resolution, from the
discovery of the first genetic markers to the current prospect of
complete sequencing on a population-wide scale. Accompa-
nying this progress has been an increasingly nuanced
appreciation of the relationship between human genotypic and
phenotypic variation. In the late 1980s and early 1990s, genetic
mapping studies identified mutations that precisely predicted
risk for numerous rare disorders with Mendelian inheritance
patterns, with Huntington’s disease being perhaps the most
widely known example within neuropsychiatry (The Huntington’s
Disease Collaborative Research Group, 1993). Mapping such
mutations using whole-genome linkage analysis and fine-
mapping association analysis became straightforward once
genomics efforts had identified sufficient numbers of polymor-
phic markers (Freimer and Sabatti, 2004). The spectacular
successes of these studies created an expectation that similarly
predictive mutations could explain risk for common diseases,
and could be identified using similar methods. This expectation
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gators, genetic mapping studies failed to implicate any such
mutations in the causation of commondisorders,with the notable
exception of a few instances in which clearly unusual families
demonstrated Mendelian transmission of a particularly distinc-
tive phenotypic variant. Examples within neurogenetics include
a rare familial form of migraine accompanied by additional
phenotypes (hemiplegia and cerebellar atrophy) and accounted
for by dominant mutations in the calcium channel gene
CACNL1A4 (Ophoff et al., 1996), or Familial Alzheimer Disease
(AD). In the latter example, thediscovery that dominantmutations
in one of three genes (APP, PS1, and PS2) are implicated in early
onset of the disorder in a small number of families has helped
transform our understanding of biological processes underlying
neurodegeneration (Selkoe and Podlisny, 2002).
The recognition in the 1990s that simple models of genetic
causation could not explain the inherited risk for common
diseases changed the direction of human genetics, emphasizing
two ways of conceptualizing their investigation that remain
central to the field today. On the one hand, it focused attention
on characterizing the genetic architecture of common diseases,
i.e., determining what number and combination of genetic vari-
ants of particular types are required to account for disease risk
in the population (Sing et al., 1996; Singleton et al., 2010). On
the other hand, it led to a realization that common diseases
required genetic dissection, i.e., that they are etiologically
heterogeneous conglomerations that can be reduced to more
homogeneous forms consequent to the discovery of risk variants
(Ehrenreich et al., 2010; Lander and Schork, 1994). The process
of genetic dissection thus characterizes the phenotypic architec-
ture of common disorders.
In the last few years, genome-level investigations have gener-
ated for some common disorders, such as type 2 diabetes (T2D)
and obesity, extraordinary advances in characterizing their
genetic architecture and the initial steps in their genetic dissec-
tion. In a small number of pedigrees, disorderswith strong clinical
similarities to T2Dandcommon formsof obesity have been asso-
ciated unequivocally with Mendelian mutations in one of several
genes;matureonset diabetesof theyoung (MODY) is aprominent
example (O’Rahilly, 2009). For both phenotypes, GWASof exten-
sive population samples have uncovered significant replicated
associations, at a genome-wide significance threshold, of
common single nucleotide polymorphisms (SNPs) representing
several dozen distinct genetic loci (O’Rahilly, 2009). Some of
these loci (e.g., GCKR) show associations to both T2D and
obesity (Diabetes Genetics Initiative of Broad Institute of Harvard
and MIT, Lund University, and Novartis Institutes of BioMedical
Research, 2007), as well as to quantitative phenotypes such as
serum lipid levels, which are highly correlated with them (Dia-
betes Genetics Initiative of Broad Institute of Harvard and MIT,
Lund University, and Novartis Institutes of BioMedical Research,
2007; Teslovich et al., 2010).
These numerous genome-wide significant findings have
served to validate the consensus standards that emerged within
human genetics at the onset of the GWAS era: genetic associa-
tion studies of complex traits should assay the entire genome,
and require stringent genome-wide significance thresholds as
well as statistically significant replication in independentsamples. However, the majority of published studies associating
genetic variation with neurocognitive phenotypes have
continued to rely upon investigations limited to one or a few
hypothesis-based candidate genes, despite the well-known
problems with this approach (Freimer and Sabatti, 2004; Glatt
and Freimer, 2002; Potkin et al., 2010; Tabor et al., 2002). The
insistence of human geneticists on genome-wide significance
thresholds for association studies reflects the extremely low
prior probability that a single gene, or a single variant within
that gene, out of the approximately 20,000 human genes (and
their multiple variants) is significantly associated with the chosen
phenotype (Freimer and Sabatti, 2004; Hariri, 2009). One justifi-
cation of candidate gene approaches is that genes chosen on
the basis of existing hypotheses could be considered to have
a higher prior probability compared to random genes. Yet there
is little to suggest that our current knowledge of the biological
pathways involved in neurocognitive function provides a suffi-
cient basis to make strongly motivated hypotheses regarding
which genes are associated with these functions. Such hypoth-
esizing is further complicated by an even greater lack of under-
standing of the potential effects of regulatory mechanisms,
epigenetic influences, and environmental factors on variation in
complex phenotypes. The notorious failures of replication in
candidate gene association studies further emphasize the fact
that most such studies have been inadequately powered to
detect associations that realistically would be expected to be
of relatively small effect. We are not aware of any evidence
that supports a contention that genome-wide significance
thresholds are less applicable to neuroimaging phenotypes
than to other measures. Indeed, the need for strict statistical
control is if anything greater in genetic association studies using
neuroimaging phenotypes, given the very high dimensionality of
the phenotypic data, which potentially greatly increases the like-
lihood of false positives.
The fact that such a large proportion of trait associations in
GWAS have occurred outside of previously proposed candidate
genes, and in many cases outside of genes altogether, has
further emphasized the futility of investigations focused on indi-
vidual hypothesis-based candidate genes. That the detection of
these associations required in almost all instances samples of at
least several thousand individuals, and in some cases tens of
thousands of individuals, also underscores how severely under-
powered most previous association studies have been.
The many common variants now known to be associated with
traits such as T2D and obesity reveal only a small proportion of
the genetic architecture of these disorders. Intensive efforts
are therefore now focused on identifying additional variants
associated with these diseases, mainly by applying next-gener-
ation sequencing technologies to identify rare base-changes
and copy number variants (CNVs) that have been barely assayed
in standard GWAS approaches. It is also likely that initial anal-
yses of GWAS of these metabolic disorders—as with most
current GWAS—have underestimated the contribution of
common variants; recent analyses suggest that a substantial
proportion of genetic risk for complex traits derives from large
numbers of common variants, each of which explains such
a minute proportion of variation that its effects do not achieve
stringent significance thresholds (Yang et al., 2010). AsNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 219
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comprehensive genetic variation data are available (Mailman
et al., 2007) in enormous samples (in some cases over 100,000
individuals), it is likely that they will be the testing ground for
a variety of new analysis approaches, e.g., for assaying effects
of gene-gene interactions.
The genetic architecture of the major psychiatric disorders, in
stark contrast to that of metabolic disorders, remains largely
unknown. To start with, for these disorders there are no unequiv-
ocal examples of Mendelian mutations implicated in unusual
families with particularly distinctive phenotypic forms, although
there are encouraging indications that rare CNVs contribute to
risk, particularly for autism and schizophrenia (Manolio et al.,
2009). The GWAS of psychiatric disorders have lagged behind
those of common nonpsychiatric disease phenotypes in identi-
fying common risk variants. For example, of the nearly 1000
published GWAS associations at genome-wide significance
thresholds for about 150 traits cataloged by the NIH (Hindorff
et al., 2009, and see http://www.genome.gov/gwastudies),
only a handful are for psychiatric phenotypes. Although, meta-
analyses of multiple GWAS for bipolar disorder and
schizophrenia have reported a few associations that could be
considered genome-wide significant and replicated (Psychiatric
GWAS Consortium Coordinating Committee et al., 2009), these
associations are sparser and show less striking significance
levels and less convincing replications than the numerous asso-
ciations observed for traits such as T2D and obesity.
Why has it been so difficult to unravel the genetic architecture
of psychiatric disease traits? One possibility is that it has largely
been a matter of inadequate sample size to identify variants that
have only a small effect on population risk for a given phenotype
(Psychiatric GWAS Consortium Coordinating Committee et al.,
2009). There are now clear examples outside of psychiatry where
replicated associations to common variants were not achieved
until sample sizes reached tens of thousands (e.g., for blood
pressure, which required a meta-analysis of more than 30,000
individuals, to identify loci that individually explain less than
0.1% of variation in systolic or diastolic blood pressure;
Newton-Cheh et al., 2009).
Yet effect size in genetic association studies is not an intrinsic
property of genetic variants, but rather an expression of the
biology of the variants in relation to the particular definition and
measurement of phenotypes in that study. Extensive heteroge-
neity in phenotypes—as is presumed to characterize all of the
major psychiatric disorders—diminishes the apparent effect of
variants contributing to phenotypic variation. There is thus great
value in any strategy that can reduce the heterogeneity of the
phenotypes under investigation. One strategy for reducing
heterogeneity has been to focus investigation on phenotypes
hypothesized to underlie particular features of disease classifi-
cations but that are more distinct, precisely and objectively
measured, and more clearly related to specific biological mech-
anisms than the disorders themselves, so called endopheno-
types (Gottesman and Gould, 2003).
Neurocognitive Phenotypes
For complex neuropsychiatric disorders, attempts to identify
endophenotypes have focused mainly on neurocognitive220 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.measures, which we define broadly as quantitative measures
of interindividual variation in brain structure and/or function
that reflect specific mental constructs (including cognition,
emotion, motivation, and personality). This focus does not imply
that variations in these domains underlie all facets of psychopa-
thology; for example, abnormalities in sleep and circadian
activity likely contribute substantially to risk for bipolar disorder
(Hasler et al., 2006). Nevertheless, overwhelming evidence links
extreme values of neurocognitive variables with several common
disorders (Bearden and Freimer, 2006; Bearden et al., 2009) and
such variables contribute to heritable phenotypic variation in
clearly Mendelian disorders as well; for example, several studies
have used quantitative measures of neurocognitive performance
in Huntington disease to obtain insight into the relationship
between brain function and behavior (Lawrence et al., 1998).
Neurocognitive measures that have been proposed as endo-
phenotypes for neuropsychiatric disorders include, among
many others, self-report trait inventories; performancemeasures
on tasks designed to assess executive function, attention,
working memory, and language; neuroanatomic measures
(of the volume of global gray and white matter, of specific struc-
tures, of cortical thickness, and of white matter structure); and
functional imaging measures to assess task-induced and resting
state activation patterns. Because the number of potential neu-
rocognitive phenotypes (what may be termed the phenomic
space) is vast, it is necessary to employ systematic criteria to
identify the neurocognitive measures that provide the best
opportunity for detecting and replicating genetic associations
that achieve acceptable thresholds of statistical significance.
Heritability
That traits must have a substantial heritable component to be
genetically mapped is obvious, and at least some data support-
ing either familial aggregation or nonrandom twin concordance
have been reported for most of the neurocognitive measures
proposed as endophenotypes for neuropsychiatric disorders
(Bearden and Freimer, 2006). Yet although the high heritability
of the disorders themselves has been established through
dozens of family and twin studies over several decades (McGue
and Bouchard, 1998), the overall level of direct evidence
supporting the heritability of self-reported trait inventories or
performance measures (such as spatial processing or response
inhibition) is limited and varies widely between traits (Bearden
and Freimer, 2006; Glahn et al., 2010a). Often the evidence
has derived from very small samples, and therefore the confi-
dence intervals around reported heritability estimates are very
large. Similarly, evidence that brain function is under genetic
influence is variable and surprisingly sparse, although those
few studies that have examined task-induced neural activation
in twin pairs have provided support for the moderate heritability
of functional brain activation in a limited set of regions of interest
(ROIs) and during performance of specific tasks (Blokland et al.,
2008; Koten et al., 2009; Matthews et al., 2007; Polk et al., 2007).
In contrast, there is substantial evidence for the high herita-
bility of neuroanatomical measures (Glahn et al., 2010b; Peper
et al., 2007; Schmitt et al., 2010; Thompson et al., 2001), and
while some publications have reported high heritability for partic-
ular structures based on analyses of very small samples, the
consistency of findings over numerous studies has given these
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genetic factors explain 80% or more of variation in structural
brain features (Glahn et al., 2007) and variation in white-matter
tract microstructure (Chiang et al., 2009; Kochunov et al.,
2010b), although the evidence for genetic effects on structure
varies across brain regions (Brun et al., 2009; Giedd et al.,
2007), as well as types of measurements (Winkler et al., 2010).
It is important, however, to keep in mind that high heritability
does not necessarily mean that a trait has a simple genetic archi-
tecture (Bearden et al., 2009). Furthermore, heritability is a popu-
lation parameter and applies to the particular population and
time studied (Visscher et al., 2008), and the variety of methods
used to assess heritability may make it very difficult to compare
heritability estimates across studies. For all of these reasons,
heritability should be considered a necessary but not sufficient
criterion in determining the feasibility of genetically mapping
a given trait. In our view characteristics of phenotype definition
and measurement—such as precision, reliability, objectivity,
and the relationship to specific mental constructs—are more
practically relevant criteria.
Phenotype Definition
Comparisons of successful and unsuccessful GWAS show
clearly the importance of precise definition of quantitative
phenotypes, of the objectivity with which they are measured,
and of the degree to which they can be related to well-character-
ized biological systems. For example, although obesity is clearly
etiologically heterogeneous, it has a simple definition that
reflects underlying biology (an abnormal increase in the total
amount of triglyceride stored in adipose tissue) and relies on
a measure that is simple and objective (the body mass index).
Accordingly, GWAS investigating differences in adiposity have
already unequivocally implicated more than 30 distinct loci (Spe-
liotes et al., 2010). An important factor in achieving these findings
has been the use of essentially identical phenotype measures
across studies, enabling well-powered meta-analyses.
In contrast, GWAS of neurobehavioral traits have often utilized
ambiguous and subjective measures and have obtained disap-
pointing results, even with substantial sample sizes. A good
example is provided by investigations of self-reported invento-
ries of temperament and personality. Self-report temperament
scales are widely investigated endophenotypes based upon
evidence for their heritability (Jang et al., 1996; Keller et al.,
2005) and for their association with psychiatric disorders (Belsky
and Pluess, 2009; De Pauw and Mervielde, 2010; Nigg, 2006).
Yet uncertainty regarding the biological underpinnings of
personality and continuing disagreement regarding the theoret-
ical basis for personality and temperament constructs have
created a situation in which several widely differing instruments
have been applied in cohorts that have undergone GWAS.
Currently reported GWAS samples for personality and tempera-
ment include more than 5000 individuals assessed for Clo-
ninger’s four temperament dimensions (Verweij et al., 2010)
and more than 10,000 subjects assessed using personality
scales based on the ‘‘Big 5’’ model (M.H.M. de Moor et al.,
2009, Behav. Genet. Assoc., abstract), and have uncovered no
genome-wide significant associations. Combination of such
samples to increase statistical power is essentially precluded
by the low correlations between these different scales.One of the few examples reported so far of unequivocal
genetic association for neurobehavioral measures—that
between nicotine dependence and variants in a cluster of nico-
tinic cholinergic receptor loci—further underscores the decisive
importance of precise and unambiguous phenotype definitions
and assays that reflect underlying biology. Bierut and colleagues
(Bierut, 2009) used simple measures obtained through subject
recall that accurately quantify an individual’s smoking behavior
and that reflect distinct phenotypes representing stages along
the path to nicotine dependence (never using, initiating smoking,
regular smoking, and nicotine dependence). The distinctiveness
of these phenotypic stages with respect to the underlying
biology of addiction provided an additional rationale for the use
of these measures in genetic association analyses. In analyses
distinguishing between individuals who smoked, but no more
than ten cigarettes a day (i.e., controls with a known exposure
to nicotine), from individuals who smoked 20 or more cigarettes
a day (Saccone et al., 2007, 2010), they identified several asso-
ciations, notably a genome-wide significant and replicated
association to variants influencing specifically the transition to
dependence. Studies that have focused on any of a myriad of
behavioral traits proposed as underlying a broader smoking
phenotype (such as risk taking, impulsivity, and susceptibility
to peer influences) have so far failed to identify such unambig-
uous associations (Saccone et al., 2007). One of the key features
of the smoking phenotype employed by Bierut and colleagues is
that its simplicity facilitated their being able to assess very large
samples, and enhanced the opportunities for replicating their
findings in other samples and incorporating their data in well-
powered meta-analyses. For some neurocognitive phenotypes,
however, it remains debatable whether it is preferable to employ
approaches that emphasize phenotype simplification, enabling
the analysis of large samples, or laborious approaches that limit
sample size but may permit the detection of distinct phenotypic
features that emphasize interindividual variability. The tension
between these alternative strategies is particularly salient for
neuroimaging, where a plethora of methods are available for
defining and measuring phenotypes.
In structural MRI analysis, some investigators continue to use
long-established methods for manual delineation of anatomical
regions, while others employ newer automated methods, which
some evidence suggests may have comparable reliability (e.g.,
Fischl et al., 2004), and there are also a number of different
schemes for defining specific anatomical phenotypes. Likewise,
in functional MRI (fMRI) there is an almost unlimited set of
analytic approaches and ways to define specific phenotypes.
A recent review of reliability of fMRI measures underscores the
limited information available across the range of tasks, prepro-
cessing steps, and summary measures commonly used, despite
the significant effect that each of these factors has on reliability
estimates (Bennett andMiller, 2010) and reproducibility (Strother
et al., 2002).
For example, although functional connectivity measures are
believed to be more reflective of integrated cognitive function
than activity is in any particular region (e.g., McIntosh, 2000),
there has been very little examination of the reliability of connec-
tivity results in task-based fMRI studies. One recent exception
(Rowe et al., 2010) demonstrated that although the overallNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 221
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showed high test-retest reliability, quantitative estimates of
connection strength were unreliable. Other recent work has
begun to examine the accuracy of connectivity estimates more
broadly using simulation methods (Smith et al., 2010), and
suggests that there are substantial differences in the ability of
different analysis methods to accurately identify connectivity
patterns. In contrast, resting state networks, which are believed
to reflect consistent functional networks engaged across tasks
and during rest, have been shown to have high test-retest reli-
ability, to be highly replicable across samples and analysis
methods, and to be significantly heritable (Glahn et al., 2010b;
Shehzad et al., 2009).
The observation that interindividual variability consistently
exceeds intraindividual variability supports the continued use of
fMRI measures as phenotypes in genetic investigations, as
does growing evidence in support of the reliability and consis-
tency of specific neural phenotypes (e.g., resting state networks).
Yet variable reliability estimates derived across tasks, prepro-
cessing steps, analysismethods, and scanners create enormous
complications for meta-analyses, limiting the possibility of ob-
taining genome-wide significance levels, much less replication.
Consistency and Replication
As we have discussed, most neuroimaging studies to date have
been severely underpowered to detect associations. Replicating
association results requires even larger samples, making the
need for phenotyping standardization and data sharing even
greater. Early in the GWAS era, it became apparent that the
magnitude of initial genetic associations is systematically
inflated, by what is known as the ‘‘winner’s curse’’ (Ioannidis,
2008). Underpowered studies are prone to large variation in
risk estimates, and only those that are positively inflated
(by noise) will be detected as significant; as a result, the initial
apparent effect is inflated and decreases in subsequent replica-
tion studies (Chanock et al., 2007). This phenomenon is inter-
esting in light of a meta-analysis of 81 association studies, which
demonstrated that journals with high impact factors tended to
publish studies with high bias scores (that is, studies that overes-
timate the true effect size) and small sample sizes (Munafo` et al.,
2009). This bias is particularly problematic in imaging genetics
studies, which may include insufficiently stringent statistical
thresholds for both the genetic effect and the neural activation,
thereby increasing the likelihood of bias.
Widespread data sharing—an essential component of the
large-scale analyses that have proven so successful for traits
such as T2D and obesity—is also a particularly acute problem
for imaging data. The sharing of whole fMRI data sets is made
challenging both by the immense size of the data sets and by
the complexity of the metadata that are necessary to describe
imaging acquisition and cognitive task paradigms. The most
prominent previous attempt to database whole fMRI data sets,
the fMRI Data Center (Van Horn et al., 2004), met with some
resistance from the field but ultimately amassed over 100 full
data sets. These data sets remain available, but the center has
not accepted any new data sets since 2006, and there is no other
current high-capacity repository for sharing of full fMRI data sets.
The desperate need for data repositories has begun to be filled
by bottom-up efforts, including the OASIS project for anatomical222 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.data (Marcus et al., 2007), the 1000 Functional Connectomes
Project for resting state fMRI (Biswal et al., 2010), and the Open-
fMRI project for task-based fMRI (www.openfmri.org). The
neuroimaging community requires the development of more
effective data sharing resources, as well as the development of
new frameworks for managing complex metadata. Efforts to
develop large-scale data sharing have already begun to bear fruit
in structural imaging studies, where standardization of pheno-
type assessment has enabled the pooling of data across large
numbers of sites. For example, in genetic association studies
of MRI measures in AD, such data pooling has permitted anal-
yses of large samples that could not be realistically obtained at
any single site (Jack et al., 2008; Petersen et al., 2010).
The Role of Ontologies in Neurocognitive Phenotyping
The understanding of neurocognitive phenotypes ismade partic-
ularly difficult by the indirect and often cloudy relation between
the tasks used to measure mental function and the underlying
mental processes that support performance on those tasks.
For example, the ‘‘n-back’’ task is often considered to measure
the construct of ‘‘working memory,’’ but detailed examination
has shown that it does not exhibit convergent validity with other
accepted measures of the working memory construct (Kane
et al., 2007). The use of performance on cognitive tasks as
a phenotype for genetic and neuroscientific investigation
requires a more systematic characterization of the mental
processes that underlie task performance. In other areas of
biomedical science, formal knowledge bases known as ontol-
ogies have become crucial in the definition of phenotypes
(Bard and Rhee, 2004). The best known and most successful
such ontology is the Gene Ontology (www.geneontology.org;
Ashburner et al., 2000), which provides a formal characterization
of cellular components, biological processes, and molecular
functions. The availability of a standard vocabulary has enabled
powerful new means of aggregation across studies.
The development of ontologies for neurocognitive function has
lagged far behind those for genetics and systems biology, but
recent work has begun to develop the semantic infrastructure
needed to support systematic cognitive phenotype character-
ization (Bilder et al., 2009b). In particular, the Cognitive Atlas
project (www.cognitiveatlas.org) has assembled an initial vocab-
ulary of mental function and is currently developing a systematic
database of mappings between mental functions and cognitive
tasks. Other parallel efforts are currently underway to develop
ontologies for the fine-grained description of cognitive tasks,
such as the Cognitive Paradigm Ontology (www.cogpo.org).
The availability of integrated knowledge bases will allow the prin-
cipled and systematic aggregation of data across different tasks
that measure the same mental constructs.
Phenomics, Other Systems-Level Approaches,
and the Reconceptualization of Phenotypes
One of the main obstacles to progress in genetic dissection of
brain and behavioral disorders is that our basic knowledge of
the function of the human nervous system remains so incomplete
in relation to that of other organ systems, making it difficult to
design studies that map the comparative genetic architecture
of particular disorders with specific neurocognitive phenotypes.
In contrast, the known strong correlation between T2D and
Figure 1. A Phenomics Approach Provides
a Coherent Conceptual System to Align
Genomic and Phenotypic Space
As this approach allows for the systematic collec-
tion of multiple phenotypes across large cohorts, it
facilitates translational efforts, data sharing, and
phenotype reconceptualization. The phenotypic
space is represented here by domains of brain
structure (high-resolution anatomical and DTI
scans provide measures of global gray and white
matter volume, region of interest volume, and
cortical thickness), and function (functional scans
provide task-induced and resting state activation
in regions of interest and across networks) and
measures reflecting neurocognitive function
(A., self-report inventories provide measures of
personality and temperament dimensions, and
B., neurocognitive tasks, such as the stop-signal
task [upper] and spatial delayed response task
[lower], measure neurocognitive performance,
including executive function, attention, working
memory, and language). The figure is not intended
to portray an exhaustive representation of neuro-
cognitive phenotypic space but rather a sample
of some of the most widely employed phenotypic
measures. Functional genomics assays provide
measures of transcript level variation, which allow
for transcript-SNP correlation and network anal-
ysis, as well as epigenome variation. The genomic
space is represented by genome-wide genetic
variation, which ranges in structural size (from
SNPs to CNVs) and frequency (from common to
rare variants). The phenotypic and genomic
spaces are not exhaustively represented (e.g.,
neurophysiologic measures are not represented)
and reflect a sample of the phenotypic space ac-
cording to some of the main approaches. DTI,
diffusion tensor imaging; rs-fMRI, resting state
functional magnetic resonance imaging; eQTL,
expression quantitative trait loci; SNP, single
nucleotide polymorphism; indels, insertions or
deletions; CNV, copy number variants.
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stimulated studies that have found differences between disease
and normal samples in the sets of SNPs associated with various
parameters of glucosemetabolism (Dupuis et al., 2010). The lack
of such established correlations for neurocognitive phenotypes
has inspired the development of several strategies for
systematically conducting joint analyses of multiple different
phenotypes in single-study samples. Such attempts to
expand—in a controlled manner—the phenotype space for
phenotype-genotype studies can be termed phenomic strate-
gies. At the same time, functional genomics information may be
used to increase the power of such studies by narrowing the
genomic space that must be searched through. Together these
phenomic and genomic strategies may be loosely categorized
as systems-level approaches.
Phenomics
What we have learned from both the successes and failures of
recent genetic investigations has underscored the importanceNeuron 68,of coherent conceptual systems for orga-
nizing phenotypes. Insights into the
genetic architecture of common diseases
gained from several successful studiesindicate that, in high-dimensional phenotypic data sets, no single
summary measure can account for the majority of phenotypic
variation; certain combinations of traits will prove to be more
informative than individual measures, or even the complete set
of measures, alone (Bloss et al., 2010; Houle, 2010). By the
conclusion of these studies highly specific correlations between
genetic and phenotypic variation may be obvious (Oti et al.,
2009; Xu et al., 2009), but for particularly complex traits such
as neurocognitive phenotypes it is rarely evident at the outset
which particular combinations of phenotypic measures should
be considered together (Houle, 2010). Phenomics, the system-
atic standardization of measures hypothesized to represent the
complete phenotypic space for a given biological system, and
their assessment in all members of a study population, has
been proposed as a framework for organizing genome-level
phenotype-genotype association studies of complex traits
(Bilder et al., 2009a) (Figure 1). This approach further implies
that the systematic assessment of multiple phenotypes in largeOctober 21, 2010 ª2010 Elsevier Inc. 223
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sharing of data across studies; establishing a common infor-
matics infrastructure for combining phenotypic and genomic
data is an important requirement for phenomics projects to
succeed.
Perhaps the most formidable obstacle in using phenomics
approaches for genetic dissection of human traits is the expense
and logistical difficulty in obtaining comprehensive phenotypic
data in samples that are large enough to support well-powered
genotype-phenotype analyses. For example, efforts to conduct
phenomic analyses using clinical databases have been largely
frustrated by the paucity of phenotypic measures relevant to
any set of disorders that they typically contain (Denny et al.,
2010). More promising sources of phenomic data may be the
databases maintained by longitudinal population cohort studies
(Freimer and Sabatti, 2003; Pembrey, 2004). Cohort databases
contain a rich array of data on diverse phenotypes and environ-
mental exposures, although, because data collections have
usually been overseen by different investigators over periods
of up to several decades, such databases are rarely either
systematic in themeasures included or comprehensive in partic-
ular phenotypic domains. Recently initiated prospective studies,
however, aim to more systematically cover the phenotype space
for genomic analysis of measures most relevant to psychiatric
disorders (Bilder et al., 2009a).
Currently, projects in a variety of animal models better high-
light than human studies the potential of phenomics approaches.
For example, mouse researchers have accepted a standard set
of protocols for extensive phenotype measurement and data
sharing. As a result, the Mouse Phenome Database (MPD),
which contains data from the systematic phenotyping of
a number of strains, now serves as a rich and comprehensive
resource for complex trait analysis (Grubb et al., 2009). While
initial attempts have beenmade to compile ‘‘orthologous pheno-
types’’ shared between mice and humans (Sardana et al., 2010),
from the standpoint of the neurocognitive phenome, nonhuman
primates (NHP) may provide more appropriate comparisons to
humans, given the close phylogenetic, anatomic, and functional
relationships between these species, as we discuss later in this
article.
Systems Genomic Approaches
Systems genomics—both experimental and bioinformatic—has
become a central component of strategies for genetically dis-
secting neurocognitive traits, as it offers a means to reduce the
genomic search space and provide biologically relevant, prom-
ising candidate genes for further genetic investigation. Measures
of quantitative gene expression provide heritable, reliably as-
sessed, and high-throughput phenotypes (Cheung et al., 2003,
2005; Jasinska et al., 2009; Monks et al., 2004; Pickrell et al.,
2010; van Nas et al., 2010), which may occupy a space interme-
diate between neurocognitive phenotypes and gene variants.
Indeed, gene expression levels have proven among the most
readily mapped quantitative phenotypes (Myers et al., 2007;
Webster et al., 2009); the genetic variants that are linked or asso-
ciated with variation in the level of expression of a given tran-
script are termed expression quantitative trait loci (eQTL). The
availability of databases annotating genome-wide SNPs with
respect to their correspondence with eQTL in various types of224 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.tissue (Gamazon et al., 2010) is likely to facilitate elucidation of
the genetic architecture of complex traits. For example, recent
analyses of such databases together with GWAS data for
a wide range of complex traits suggest that eQTL detected in
studies of lymphoblast cell lines are much more likely to corre-
spond to the SNPs that have demonstrated association with
complex traits than to other SNPs in the database (Nicolae
et al., 2010). Such use of eQTL-annotation databases not only
may improve the precision of estimates of effect size for genetic
associations, but provides information on the biology underlying
particular associations.
One of the major questions in using gene expression profiles
as tools in genetic dissection of neurocognitive traits concerns
the applicability of gene expression measures in peripheral
blood to expression patterns in less accessible tissue such as
the brain. Recent evidence suggests that, for many genes, stable
interindividual variation in expression levels in peripheral blood
correlates strongly with such variation in brain (Jasinska et al.,
2009; Rollins et al., 2010). As data become available from inves-
tigations of transcriptome variation in increasingly large numbers
of individuals and tissues, and as the sensitivity and specificity of
such studies advance through the employment of direct RNA
sequencing (Babak et al., 2010; Pickrell et al., 2010), we antici-
pate that transcriptome analysis will have a transformative
impact on the genetic dissection of neurocognitive traits.
As genetic investigation of complex neurocognitive pheno-
types increasingly turns to the collection of phenomic and
genomic data, the integration of such data represents a substan-
tial challenge for their joint analysis.Whereas current approaches
mostly treat both neural and genetic data as large sets of inde-
pendent observations, both brain function and gene expression
are better characterized as complex interacting networks (Bull-
more andSporns, 2009;Geschwind andKonopka, 2009; Schadt,
2009) that are amenable to the broad set of methods developed
for network analysis (Newman et al., 2006). These methods offer
theability to greatly reduce thedimensionality of thedata for anal-
ysis, while still respecting the complex structure inherent in those
data. For example, using network analysismethods, it is possible
to reliably identify neighborhoods of voxels across the brain that
are functionally integrated and serve as nodes in a larger con-
nected network (e.g., Cohen et al., 2008; Mumford et al., 2010);
the aggregate signal from within these neighborhoods can then
be used for subsequent analyses, greatly reducing the dimen-
sionality of the data and thus the stringency required to appropri-
ately correct for multiple comparisons. Recent work using such
network analyseshas shown that it is possible todetect individual
differences in network connectivity that are not evident in overall
activation (e.g., Fair et al., 2007). Indeed, the use of network anal-
ysis approaches is likely to have particular value in genome-wide
imaging genetics studies, as they provide a means of reducing
the dimensionality of imaging data, thereby making genome-
wide analyses feasible, while providing phenotypes that do not
depend on a priori assumptions about brain structure yet can
be related to what is known about brain function.
Network analysis approaches to gene expression data have
also been successful in providing a systems-level understanding
of gene function. Such analyses have revealed that expression in
the human cerebral cortex is organized into modules that reflect
Figure 2. Nonhuman Primate Model Representing a Comprehensive Phenomic Approach
The assessment of multilevel sets of measures in extended nonhuman primate (NHP) multigenerational pedigrees provides complete coverage of the phenotypic
space and sufficient power for linkage and association analysis with comprehensive genome-level genetic variation data. Examples are shown here from the
Integrated Vervet/African Green Monkey Research and Resources Consortium (http://www.genomequebec.mcgill.ca/compgen/vervet_research/). The multi-
level analysis of neurocognitive traits in this model system (see highlighted text) is illustrated by the genetic mapping of a QTL for the dopamine catabolite ho-
movanillic acid (HVA) in an extended vervet pedigree (Freimer et al., 2007). Other neurocognitive phenotypes assessed in this pedigree that are hypothesized to
be influenced by dopaminergic function include measures of impulsivity and reversal learning and are therefore candidates for inclusion in multivariate pheno-
type-genotype analyses along with HVA levels and relevant gene expression variation. The genomic resources available for such analyses (illustrated here by
a screenshot of a customized UCSC Genome Browser track) include genome-wide sequence, genetic variation, and gene expression data. Details of the
Genome Browser screenshot include nucleotide position; microsatellites; concordantly and discordantly mapped BAC clone ends; 454 short sequence read
coverage from The Genome Center at Washington University; and vervet brain gene expression using Human Genome U133 Plus 2.0 Array from Affymetrix.
MRI, magnetic resonance imaging; Actigraphy is the measurement of body movement patterns to infer sleep/wake and rest/activity cycles.
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Perspectivecell classes (Oldham et al., 2008) and distinct brain regions (Old-
hamet al., 2006), and that gene coexpression networks in human
and chimpanzee brains can be used to quantify conservation
across brain regions (Oldham et al., 2006). Network analysis
approaches to gene expression data are beginning to elucidate
relationships between biology and function in ways not possible
by using standard methods of analysis.
The next step is to integrate data across levels of analysis. In
this way, network analysis approaches can be used to embrace
the high dimensionality of the data and provide a context in
which to interpret genotype-phenotype associations (Schadt,2009). That is, as opposed to univariate approaches, which
require correction of nonindependent traits, or data dimension-
ality reduction approaches that either result in indirect factors
that are difficult to interpret or qualitative descriptors, recent
multivariate approaches have been developed that reduce
data dimensionality while still retaining information about
complex phenotypes. These approaches include ways to
account for information contained within quantitative trait
networks for incorporation in genetic association analyses (Kim
and Xing, 2009), as well as ways to allow for the simultaneous
investigation of latent (factor) and specific (variable) testsNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 225
Neuron
Perspective(Medland and Neale, 2010). The recent work by Mumford et al.
(2010), in which methods originally developed for the analysis
of gene networks were profitably used to analyze fMRI activation
networks, further suggests that it should be possible to integrate
across these very different levels of analysis with the use of
network modeling strategies.
Systems-Level Investigations in Nonhuman Primates
Investigations of rodent models have played an important role in
the genetic dissection of traits such as obesity (Yang et al., 2009),
but have so far had less impact on our understanding of disor-
ders of brain and behavior (Nestler and Hyman, 2010). Yet
numerous limitations to investigations of the human brain neces-
sitate the employment of animal genetic models, particularly for
systems-level investigations that may be infeasible in humans.
Recent large-scale efforts aimed at characterizing genetic and
functional variation in several NHP genomes have made NHP
models increasingly important as bridges between rodents and
humans. Phenome-level investigations are now underway in
several of themost widely employedNHP species, including rhe-
sus macaques, vervet monkeys (also termed African green
monkeys), and baboons. Advantages of these systems include
the opportunities for longitudinal genetic and genomic studies
incorporating a wide range of assays across the lifespan, as
well as for studies assessing interindividual variation in medically
relevant interventions (e.g., drug response). In particular, the
possibility of obtaining biological materials that are largely inac-
cessible in humans—for example, tissues that enable the inves-
tigation of functional genomic variation between brain regions,
between the brain and peripheral organs, and across the life-
span—creates the opportunity for phenomic analyses that are
truly comprehensive. An additional important factor in the
genetic investigation of NHPs is that environmental contributions
to trait variance (such as diet or social interactions) can be
controlled or at least documented to a far greater degree than
is possible in human studies; diminished variance in shared envi-
ronments likely contributes to findings of higher heritability in
NHPs over those of humans for traits such as the size of various
brain structures (Fears et al., 2009). The precision of heritability
estimates in NHPs has also been enhanced by the availability
of large, well-powered pedigree samples for assessing complex
phenotypes that could not readily be assayed in comparable
human families. For example, Oler et al. (2010) used high-resolu-
tion 18F-labeled deoxyglucose positron-emission tomography
(FDG–PET) in more than 200 rhesus macaques from a single
pedigree to demonstrate significant interindividual differences
in a behavioral trait (anxious temperament), which were corre-
lated with brain region-specific variations in glucose metabolism
(Oler et al., 2010). They were able to further determine that the
heritability of the metabolic phenotype differed significantly
between regions known to be important components of the
circuitry underlying the behavioral trait.
The genetic dissection of complex neurocognitive phenotypes
is already underway, through linkage and association studies
now being conducted in well-powered NHP pedigree or popula-
tion samples. Examples of such phenotypes include dimensions
of impulsivity and working memory (James et al., 2007), features
of brain structural variation (Fears et al., 2009; Kochunov et al.,
2010a; Rogers et al., 2007; Rogers et al., 2010), and measures226 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.reflecting central dopamine turnover (Freimer et al., 2007). The
restricted genetic and environmental heterogeneity that we
postulate characterizes several NHP study samples likely
accounts for the large effect size observed for QTL mapped in
such samples, as illustrated by a locus for central dopamine turn-
over in the vervet monkey that accounts for about 60% of the
heritable variance for this trait within the Vervet Research Colony
(Freimer et al., 2007). Genetic investigations in NHP will soon be
aided by the anticipated availability in such species of eQTL
reflective of transcriptome variation in multiple tissue types (Ga-
mazon et al., 2010; Jasinska et al., 2009) (Figure 2). Additionally,
efforts to bank samples from large numbers of unrelated NHPs
will soon generate opportunities to conduct well-powered
studies that could detect associations to loci of smaller effect
than those that can be identified in pedigree samples (http://
www.genomequebec.mcgill.ca/compgen/vervet_research/;
Kanthaswamy et al., 2009).
Reconceptualization of Phenotypes Based on Genetic
Dissection
The promise of genetic dissection is that it provides a more
precise alignment of genotypic and phenotypic variation. As
we have discussed already, obtaining sufficient power for the
discovery phase in the genetic dissection of complex traits
requires sample sizes that are unrealistic to obtain for certain
phenotypic measures with inescapably low throughput, such
as fMRI. Even relatively modest samples, however, can be suffi-
ciently powerful for the hypothesis-based process of genetic
dissection that must occur after the identification of significant
and replicated associations to a related trait; because of such
strong prior genetic evidence, a genome-wide level of signifi-
cance is not required in these studies. The follow-up of signifi-
cant association signals using neuroimaging paradigms offers
a means of elucidating mechanisms and, as has been recently
argued, represents a new role of endophenotypes in the
GWAS era, for functional characterization of common disorders
(Hall and Smoller, 2010).
Examples of this use of neuroimaging phenotypes include
several studies undertaken to better understand the effects of
particular apolipoprotein E (APOE) genotypes in relation to cogni-
tive performance. The e4 allele of APOE, which is the predomi-
nant risk variant for common forms of AD, has been repeatedly
associated with disease risk, as well as with differences in cogni-
tive abilities in premorbid individuals (Bookheimer and Burggren,
2009). Given the reproducibility of the association between this
variant and risk for AD in large samples, findings of genotype
group differences in MRI measures of brain activation and struc-
ture in modestly sized samples represent a clear demonstration
of the use of such low-throughput measures to elucidate mecha-
nisms (Burggren et al., 2008; Donix et al., 2010; Reiman et al.,
2004). Inparticular,Wolketal., (2010)demonstratedadissociable
effect ofAPOEgenotypeoncognitive andneuroanatomic pheno-
types in a sample of patientswithmild AD.APOE e4 allele carriers
were significantly impaired in episodicmemory performance and
had reduced cortical thickness in the medial temporal lobe, as
well as smaller hippocampal volumes, as compared with the
noncarriers, while the noncarriers were significantly impaired in
tasks of attention and executive function, and had reduced
cortical thickness in all other ROIs previously implicated in AD.
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PerspectiveThe example of APOE and measures related to AD remains
a singular one, given that the effect size on AD of the e4 allele
is so large. The impact of GWAS findings in metabolic disorders,
however, illustrates how even variants with a small apparent
effect can contribute to the reconceptualization of phenotypes.
Some of the strongest associations observed for commonmeta-
bolic disorders occur at loci whose presumed function centers
on neurobehavioral contributions to obesity (O’Rahilly, 2009).
Such findings have contributed to increased recognition that
biological overlaps between metabolic and neurocognitive
systems may be important in a wide range of human disorders.
This possibility has also been raised by basic studies in model
organisms (e.g. Marcheva et al., 2010) and by findings such as
the discovery of high-penetrance deletions responsible for
extreme obesity phenotypes, which were first uncovered in indi-
viduals with various cognitive disorders (Walters et al., 2010).
As discussed previously, there are not yet sufficient replicated
associations for psychiatric disorders for such phenotypic rec-
onceptualization to have occurred. However, findings from initial
large GWAS of such disorders have begun to suggest how
systematic genetic dissection of neurocognitive phenotypes
may be helpful in this regard. A recent meta-analysis of case-
control GWAS data indicates the existence of a substantial,
shared genetic component between schizophrenia and bipolar
disorder that is not shared with several nonpsychiatric diseases
and that reflects common variants of small effect on these
phenotypes (International Schizophrenia Consortium et al.,
2009). It is unlikely, however, that the phenotypic data available
in such case-control samples will permit detection of specific
features that are responsible for such overlap, and that could
suggest the underlying biological mechanisms. Genetic anal-
yses focused on comprehensive sets of neurocognitive pheno-
types, however, could be useful for this purpose.
Conclusions
Identification of variants associated with a wide range of neuro-
cognitive phenotypes could provide a foundation for the system-
atic genetic dissection of normal brain function as well as that of
brain dysfunction. Achieving this goal will require high-
throughput assessment in large samples using measures that
are precisely defined and reliably assayed, and unambiguously
reflect underlying mental functions. Although neuroimaging
variables remain among the most promising neurocognitive
phenotypes for genetic investigation, the validation and stan-
dardization of imaging-based phenotypes remains a critical
challenge. Implementation of systems-level approaches—phe-
nomic as well as genomic—offers a potentially powerful
approach for identification of genetic variants associated with
neurocognitive traits, but may require application of strategies
such as network analysis for reducing the dimensionality of
immense data sets. Once we obtain unequivocal associations
for neurocognitive phenotypes, characterizing the pathways by
which these genetic variants affect mental function will produce
additional challenges. It will be difficult in many cases to identify
and characterize the function of the specific genetic variants
implicated by these associations; comparative investigations
including both traditional animal models, as well as NHP
systems, may be important in this endeavor. Additionally, it willlikely be a slow process to relate the genetic architecture identi-
fied for neurocognitive traits to phenotypic features in clinical
samples that represent potential targets for either therapeutic
interventions or prevention strategies. The development of vali-
dated and standardized phenotypes will provide the scaffold
on which these difficult tasks can be performed.
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